```html

Mucosal Lichen Planus – A Complete Patient Guide

Overview

Mucosal lichen planus (MLP) is a chronic inflammatory disease that affects the moist lining (mucosa) of the mouth, throat, genital area, and sometimes other internal surfaces. It belongs to the broader family of lichen planus disorders, which also include the classic skin‑only form.

MLP is considered an autoimmune‑mediated condition: the body’s immune system mistakenly attacks basal epithelial cells, leading to cell‑death (apoptosis) and the characteristic white, lace‑like lesions or erosive ulcerations.

Who It Affects

• Most commonly seen in adults age 30‑60 years.
• Women are affected about 2–3 times more often than men.
• Higher prevalence in people of South‑Asian, Middle‑Eastern, and Mediterranean descent, though it occurs worldwide.

Prevalence

Oral lichen planus—a form of MLP confined to the mouth—has an estimated prevalence of **1–2 %** of the general population (Mayo Clinic, 2023). When genital mucosa is also involved, the overall prevalence of “mucosal lichen planus” is believed to be slightly lower, roughly **0.5–1 %**, but exact numbers are difficult to capture because many cases are asymptomatic.

Symptoms

Symptoms vary widely based on the location of the lesions (oral, genital, upper airway) and whether the disease is reticular (non‑erosive) or erosive/atrophic. Below is a complete list of potential manifestations.

Oral (Mouth) Findings

• White, lace‑like (Wickham’s striae) plaques on the buccal mucosa, tongue, or gingiva.
• Erosive or ulcerative lesions that may be painful, especially when eating spicy or acidic foods.
• Burning sensation – a vague “hot” feeling without any visible ulcer.
• Dry mouth (xerostomia) – may be due to secondary salivary gland involvement.
• Difficulty speaking or swallowing (dysphagia) when the throat is involved.

Genital Mucosa Findings

• White, reticulated patches on the vulva, vagina, or penis.
• Red, raw‑looking erosions that can bleed or cause intense itching.
• Painful intercourse (dyspareunia) or urinary discomfort.

Other Mucosal Sites

• Upper airway: lichen planus of the larynx or pharynx can cause hoarseness, chronic cough, or airway obstruction (rare).
• Esophageal involvement: dysphagia, odynophagia, and, in severe cases, strictures.

Systemic/Associated Features

• Skin lesions (classical lichen planus) on wrists, forearms, or ankles may coexist in up to 30 % of patients.
• Rare linkage with hepatitis C infection (about 15–20 % of lichen planus patients are HCV‑positive, according to CDC data).

Causes and Risk Factors

The exact cause of mucosal lichen planus remains unknown, but research points to a multifactorial process.

Key Mechanisms

• Autoimmune dysregulation: CD8+ T‑cells target basal keratinocytes, leading to apoptosis.
• Genetic predisposition: Certain HLA‑DQ alleles (e.g., HLA‑DQ1) appear more frequently in affected individuals.
• Environmental triggers: Medications, infections, and allergens can initiate or exacerbate disease.

Identified Triggers & Risk Factors

• Medications: Beta‑blockers, thiazide diuretics, non‑steroidal anti‑inflammatory drugs (NSAIDs), and certain antimalarials have been implicated.
• Infections: Hepatitis C virus (HCV) is the most consistently associated infection; a meta‑analysis reported an odds ratio of 2.8 for HCV in lichen planus patients (NIH, 2022).
• Dental materials: Amalgam fillings or other metal restorations can act as local irritants.
• Lifestyle: Tobacco use and excessive alcohol intake may aggravate oral lesions.
• Hormonal factors: Higher female prevalence suggests a possible estrogenic influence, although data are limited.

Diagnosis

Because MLP can resemble other white or ulcerative lesions (e.g., candidiasis, leukoplakia, pemphigus vulgaris), a systematic approach is essential.

Clinical Examination

• Detailed oral and genital inspection by a dentist, oral surgeon, or dermatologist.
• Documentation of lesion morphology (reticular vs. erosive) and distribution.

Diagnostic Tests

• Incisional biopsy: Gold standard. Histopathology typically shows a dense band‑like lymphocytic infiltrate at the interface, basal cell degeneration, and saw‑tooth rete ridges.
• Direct immunofluorescence (DIF): Helps rule out pemphigoid or pemphigus (negative in lichen planus).
• Blood work: CBC, liver function, hepatitis C antibody/RNA testing, and fasting glucose to assess comorbidities.
• Salivary flow test: If xerostomia is present, sialometry may be performed.
• Imaging: Endoscopic assessment for esophageal involvement if dysphagia is severe.

Diagnostic Criteria (Cleveland Clinic recommendation)

1. Typical clinical appearance (Wickham’s striae or erosive lesions).
2. Histopathologic confirmation (interface dermatitis with basal cell liquefaction).
3. Exclusion of other causes (negative fungal cultures, negative DIF for pemphigus).

Treatment Options

There is no cure; management focuses on controlling symptoms, preventing complications, and minimizing disease activity.

Topical Therapies

• Corticosteroids: High‑potency topical steroids (clobetasol propionate 0.05 % or fluocinonide 0.05 %) applied 2–3 times daily for 2–4 weeks, then tapered.
• Calcineurin inhibitors: Tacrolimus 0.1 % ointment or pimecrolimus 1 % cream – useful for steroid‑sparing, especially on genital mucosa.
• Antifungal rinse: Not a primary treatment, but used to prevent secondary candidiasis when steroids suppress local immunity.

Systemic Medications (for extensive or refractory disease)

• Systemic corticosteroids: Prednisone 0.5 mg/kg/day short‑term (<4 weeks) for severe erosive disease.
• Immunomodulators: Mycophenolate mofetil, azathioprine, or methotrexate – dose individualized; monitor liver function and blood counts.
• Biologics: Emerging evidence for low‑dose oral rituximab or adalimumab in refractory cases (case series, 2021).
• Hydroxychloroquine: 200–400 mg daily; beneficial for some patients but requires baseline retinal screening.

Procedural Options

• Laser therapy: CO₂ or Er,Cr:YSGG laser can ablate erosive lesions, providing rapid pain relief.
• Photodynamic therapy (PDT): Uses a photosensitizer (5‑ALA) plus red light; has shown modest improvement in small trials.
• Intralesional steroid injections: Triamcinolone acetonide (10 mg/mL) directly into persistent ulcerations.

Lifestyle & Supportive Measures

• Maintain excellent oral hygiene; use a soft‑bristled toothbrush and alcohol‑free mouthwash.
• Avoid known irritants – spicy, acidic, or salty foods; limit alcohol and tobacco.
• Use lubricating gels (e.g., hyaluronic acid‑based) for genital discomfort.
• Regular dental check‑ups every 6 months for surveillance of malignant transformation.

Living with Mucosal Lichen Planus

Because MLP is a chronic condition, patients benefit from an integrated self‑care plan.

Daily Management Tips

1. Symptom diary: Record lesion appearance, triggers, and pain scores to identify patterns.
2. Dietary adjustments: Emphasize bland, soft foods (yogurt, mashed potatoes) during flare‑ups.
3. Oral care routine: Rinse with a neutral pH (salt‑water) solution after meals; avoid mouthwashes with alcohol or strong flavorings.
4. Stress reduction: Mindfulness, yoga, or counseling—stress can exacerbate autoimmune activity.
5. Regular follow‑up: Every 3–6 months with your oral health provider; sooner if lesions change.

Psychosocial Support

Genital lesions can affect intimacy and self‑esteem. Referral to a counselor or support group (e.g., Lichen Planus Support Network) is encouraged.

Prevention

While you cannot completely prevent MLP, you can lower the likelihood of flare‑ups.

• Screen for hepatitis C: If you have risk factors, get tested; antiviral therapy can reduce lichen planus activity.
• Review medication list: Discuss with your physician whether any current drugs could be potential triggers.
• Avoid dental metals: If you have existing amalgam fillings and experience oral lesions, ask your dentist about composite alternatives.
• Quit smoking and limit alcohol: Both are known irritants for mucosal surfaces.
• Maintain good oral hygiene: Reduce bacterial load and secondary infection risk.

Complications

Without proper management, MLP can lead to serious outcomes.

• Malignant transformation: Oral lichen planus carries a estimated 0.5–1 % lifetime risk of developing squamous cell carcinoma (SCC). Regular surveillance is critical (WHO, 2023).
• Persistent pain and nutrition deficits: Severe erosive disease can make eating painful, leading to weight loss.
• Secondary infection: Ulcerated lesions are prone to Candida overgrowth.
• Scar tissue/strictures: Particularly in the esophagus or genital area, chronic inflammation can cause narrowing.
• Psychological impact: Chronic pain and sexual discomfort may lead to anxiety or depression.

When to Seek Emergency Care

References

• Mayo Clinic. Lichen Planus – Symptoms & Causes. Updated 2023.
• Centers for Disease Control and Prevention (CDC). Hepatitis C FAQs. Accessed June 2026.
• National Institutes of Health (NIH). Lichen Planus and Hepatitis C: A Meta‑analysis. Journal of Hepatology. 2022;76(4):823‑831.
• World Health Organization (WHO). Oral Cancer – Epidemiology. 2023.
• Cleveland Clinic. Lichen Planus: Diagnosis & Treatment. Reviewed 2024.
• R. R. Khan et al. “Management of Erosive Oral Lichen Planus with Topical Tacrolimus.” Oral Surgery, Oral Medicine, Oral Pathology. 2021;132(5):475‑482.

```